your partner in preclinical research

Latest Posts

> 2017 Oct

Part of the Repositive PDX comsortium.

Urosphere / Urolead is proud to be part of the Repositive PDX comsortium.

Read more

> 2017 Oct

Acquisition of Urolead company.

Urosphere is pleased to announce its acquisition of Urolead company.

Read more

> 2017 Sep

Urosphere will be present at the International Continence Society 2017

Urosphere will present an oral communication at ICS (Florence, 12-15 september 2017)

Read more

> 2017 Mar

Urosphere will be present at the European Association of Urology congress 2017

Urosphere will present two posters at the 32st annual EAU congress (24-28 March 2017).     

Read more

> 2016 May

Urosphere presented two posters at ERA-EDTA congress

Urosphere presented two posters in collaboration with Solid Drug Development at the 53rd annual ERA-EDTA congress: Effect of JNK inhibitor in a rat model of renal ischemia-reperfusion injury (link) Effects of JNK inhibitor on puromycin aminonucleoside-induced nephropathy in rats (link) Please click on links next to the posters titles to see them.

Read more